<DOC>
	<DOC>NCT01900834</DOC>
	<brief_summary>This study is conducted in the United States of America (USA). The aim of this study is to assess longitudinal variation of immune biomarkers in subjects with type 1 diabetes (T1D), type 2 diabetes (T2D) and healthy, non-diabetic subjects over a one year period.</brief_summary>
	<brief_title>Evaluation of Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<criteria>T1D Male or female subjects diagnosed within the last 3 years and with good general health based on medical history Age above or equal to 14 years and below or equal to 40 years Body weight above 45 kg T2D Male or female subjects diagnosed within the last 15 years with good general health based on medical history HbA1c between 6.5% and 10% Body mass index (BMI) below 45 kg/m^2 Age above or equal to 18 and below 65 years On insulin treatment HS Male or female subjects with good general heath based on medical history Age above or equal to 18 years and below or equal to 40 years Any chronic disorder (besides T1D or T2D) or severe disease which, in the opinion of the investigator, might jeopardize subject's safety or compliance with the protocol Female of childbearing potential who is pregnant, breastfeeding, or intends to become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>